Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer
Clinical trial NCT07402473 · RECRUITING
Trial details
- NCT number
- NCT07402473
- Sponsor
- Rutgers, The State University of New Jersey
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2027-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.